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Endothelial-to-mesenchymal transformationCardiac valves originate from endocardial cushions (EC) formed by endothelial-to-mesenchymal transforma-
tion (EMT) during embryogenesis. The zinc-ﬁnger transcription factor Snai1 has previously been reported to
be important for EMT during organogenesis, yet its role in early valve development has not been directly ex-
amined. In this study we show that Snai1 is highly expressed in endothelial, and newly transformed mesen-
chyme cells during EC development. Mice with targeted snai1 knockdown display hypocellular ECs at E10.5
associated with decreased expression of mesenchyme cell markers and downregulation of the matrix metal-
loproteinase (mmp) family member,mmp15. Snai1 overexpression studies in atrioventricular canal collagen I
gel explants indicate that Snai1 is sufﬁcient to promote mmp15 expression, cell transformation, and mesen-
chymal cell migration and invasion. However, treatment with the catalytically active form of MMP15 pro-
motes cell motility, and not transformation. Further, we show that Snai1-mediated cell migration requires
MMP activity, and caMMP15 treatment rescues attenuated migration defects observed in murine ECs follow-
ing snai1 knockdown. Together, ﬁndings from this study reveal previously unappreciated mechanisms of
Snai1 for the direct regulation of MMPs during EC development.AHA Predoctoral Fellowship
MSB 6048 (R189), Miami, FL,
.
rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
Development of heart valve structures is a complex process involv-
ingmultiple molecular pathways that modulate cardiacmorphogenesis
(Combs and Yutzey, 2009; Srivastava, 2000). Alterations in these genet-
ic networks during embryogenesis frequently lead to structural defects,
malfunction and congenital heart disease (CHD) in approximately 1% of
all live births (Hoffman and Kaplan, 2002). These commonly include
valvular and septal defects that often require multiple corrective sur-
gical procedures, or result in death in utero, childhood, or infancy
(Lloyd-Jones et al., 2010). Despite the clinical signiﬁcance, the inter-
secting regulatory pathways required for normal heart valve formation,
and their genetic contributions to CHD are not complete. Understanding
the structure–function relationship of genes important during embry-
onic valvulogenesis will provide insights into genetic causes of CHD as-
sociated with structural valve defects and dysfunction.
Heart valve formation is initiated in the atrioventricular canal (AVC),
outﬂow tract (OFT) regions around embryonic day (E) 9.5 in the mouseand E3.0 in the chicken, following expansion of existing cardiac jelly
and formation of endocardial cushions (ECs) (Combs and Yutzey, 2009;
Person et al., 2005). ECs are reservoirs for a heterogeneous population
of precursor cells that later remodel and give rise to the mature, and
highly diversiﬁed heart valve structures (Lincoln et al., 2004). The cellu-
lar and molecular processes required for EC formation are critical to
normal valve development and require endothelial-to-mesenchymal
transformation (EMT) (Person et al., 2005). The EMT program involves
several phenotypic changes of endothelial cells and is not restricted to
ECs, but critical for the development of many tissues during embryo-
genesis (Barrallo-Gimeno and Nieto, 2005). In developing ECs, EMT ini-
tiation is characterized by delamination of a subset of endothelial cells
overlying the future valve site following down regulation of adhesion
molecules and lost cell–cell contacts (Person et al., 2005; Thiery et al.,
2009). Subsequently, endothelial cells break away from their neighbors,
transform into mesenchymal cells and acquire motile properties, allow-
ing invasion andmigration through thematrix-rich cardiac jelly (Person
et al., 2005). Once migrated, these highly proliferative mesenchymal
cells populate the ECs and form elongated valve primordia that continue
to grow and elongate into mature leaﬂets and chordae tendinae in the
AV valves and cusps in the OFT and pulmonic regions (Hinton et al.,
2006; Lincoln et al., 2004, 2006b). Numerous signaling pathways have
been shown to regulate EC EMT (Armstrong and Bischoff, 2004; Combs
and Yutzey, 2009; Person et al., 2005). These include growth factors
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proteins (Bmp) and transforming growth factors (Tgfβ), as well as more
localized signaling fromWnt- and Notch-related pathways (Armstrong
and Bischoff, 2004; Combs and Yutzey, 2009; Person et al., 2005). Tar-
geted mutations in receptors, ligands or downstream mediators of
these pathways have previously been shown to have detrimental effects
on EC development and embryo survivability (Combs and Yutzey, 2009;
Person et al., 2005), highlighting the importance of the EMT process for
normal heart valve formation and cardiac function.
Members of the Snail family of transcription factors including snai1
(snail), and snai2 (slug) have previously been shown to play major
roles in EMT inmany developmental systems during embryogenesis, al-
though direct roles for snai1 in the heart have not been examined (Cano
et al., 2000; Niessen et al., 2008). Snai1−/−mutantmice die early in ges-
tation due to defective gastrulation and mesoderm formation as cells
fail to migrate because they cannot undergo EMT (Carver et al., 2001).
Parallel studies have revealed that snai1 positively regulates EMT by di-
rectly repressing cell adhesion genes including E-cadherin (Batlle et al.,
2000; Cano et al., 2000), claudins and occludins (Ikenouchi et al., 2003;
Martinez-Estrada et al., 2006) and therefore cell–cell contacts are ad-
versely maintained in snai1mutant mice. In the absence of snai1, com-
pensation by the homologous family member snai2 is not sufﬁcient to
rescue the lethal phenotype (Carver et al., 2001). Although snai2−/−
mice are viable as a result of snai1 compensation (Jiang et al., 1998;
Murray et al., 2007) and reports describe impaired cell migration and
transformation in ECs (Niessen et al., 2008; Romano and Runyan,
1999). However, as one might expect, compensatory increases in
snai1 expression are sufﬁcient to rescue the reduced EC cellularization
observed in embryonic snai2−/− mice (Niessen et al., 2008). Together,
these studies highlight the importance of Snail family members during
EMT and embryonic development.
In this study we aim to determine the direct role of Snai1 during EC
formation using a mouse model with conditional reduced snai1 func-
tion and established in vitro systems. We demonstrate that Snai1 is
highly expressed in overlying endothelial cells and transformedmesen-
chymal cells within the developing ECs, although expression is signiﬁ-
cantly downregulated during later, post-EMT stages of valvulogenesis.
Mice with conditional heterozygous loss of snai1 in endothelial-derived
cells (Tie2cre;Snai1ﬂ/+) display fewer cells within the cardiac jelly of de-
veloping ECs, associatedwith reduced expression ofmesenchymal gene
markers. In addition, AVC regions from Tie2cre;Snai1ﬂ/+ mice at E10.5,
express signiﬁcantly lower levels of the matrix metalloproteinase
(mmp), mmp15 (MT2-MMP). Using the established collagen I gel ex-
plant assays (Bernanke and Markwald, 1982; Lincoln et al., 2006a;
Runyan and Markwald, 1983), we show that treatment of AVC ex-
plants with adenovirus-targeting Snai1 (AdV-Snai1) promotes mmp15
expression and several EMT processes including cell transformation, in-
vasion and migration. In contrast, treatment with a catalytically active
MMP15 protein (caMMP15) promotes only cell motility. Further, phar-
macological inhibition of MMP activity prevents Snai1-mediated mes-
enchyme cell migration, while caMMP15 treatment is sufﬁcient to
rescue attenuated migration phenotypes observed in AVC explants
with targeted snai1 knockdown. Additional co-immunoprecipitation
and luciferase assays indicate that Snai1 binds, and transactivates
E-box-rich regions within mmp15. However, in the presence of the
E2A family member, E47, Snai1 repressmmp15. Together, these studies
support a direct role for Snai1 in ECdevelopment, and identify previous-
ly unappreciated mechanisms of mmp15 activity, regulated by snai1,
for cell motility during EC EMT.
Materials and methods
Histological analysis
Whole mouse and chicken embryos staged at embryonic day (E)
10.5 (mouse) and Hamburger Hamilton stage (HH St.) 14 (E2.5-3.0)were collected in 1× Phosphate Buffered Saline (PBS) and either
ﬁxed in 4% paraformaldehyde (PFA) overnight at 4 °C or left unﬁxed.
Fixed tissues were subsequently processed for parafﬁn embedding
and 6 μm tissue sections were cut as previously described (Lincoln
et al., 2006a). Alternatively, unﬁxed tissue was immediately pro-
cessed for frozen block cryoembedding (Lincoln et al., 2006a) and
12 μm tissue sections were cut. For colorimetric and ﬂuorescent immu-
nohistochemistry, ﬁxed tissue sections were processed (Lincoln et al.,
2007) and incubated overnight at 4 °C with primary antibodies against
Snai1 (Abcam, 1:500), Smooth Muscle α-Actin (αSMA) (Invitrogen,
1:500), and Phospho-histone H3 (Upstate, 1:200). In contrast, unﬁxed
frozen sections were post ﬁxed in ice-cold acetone at −20 °C for
15 min, blocked in 5% bovine serum albumin/1xPBS for 30 min and in-
cubated with anti-matrix metalloproteinase 15 (Mmp15) (Abcam,
1:200) for 2 h at room temperature. Antigen retrieval was used for the
detection of Snai1, Mmp15 and Phospho-histone H3 by boiling tissue
sections in unmasking solution (Vector Labs) for 10 min and allowing
to cool to room temperature prior to blocking. Detection using diamino-
benzidine (DAB) was performed according to the manufacturer's in-
structions (ABC staining system, Santa Cruz Biotechnology) and
visualized on anOlympus BX51microscope. Immunoﬂuorescent staining
was performed using appropriate secondary antibodies (Alexa-Fluor)
and captured using Olympus Fluoview F-1000 confocal microscope.
Alcian blue staining was performed on parafﬁn tissue sections from
E10.5 and E13.5 Tie2cre;Snai1ﬂ/+ embryos and counter-stainedwith nu-
clear fast red solution as previously reported (Lincoln et al., 2007).
Generation of adenoviruses
Full-length FLAG-tagged mouse snai1 cDNA was generated by PCR
ampliﬁcation from E14.5 mouse limb template and ligated into the
pShuttle-IRES-hrGFP-1 vector (Stratagene). In parallel, a control ade-
noviral construct was generated with no cDNA insert (AdV-GFP). Ad-
enovirus generation and tittering were performed according to the
manufacturer's instructions using the AdEasy XL and AdEasy Viral
Titer kits respectively (Stratagene). For AdV-Snai1 and AdV-GFP, in-
fection efﬁciency was determined by counting the number of GFP-
positive cells over the number of DAPI-positive nuclei in at least 5 mi-
croscopic ﬁelds (n=4). The AdV-cre was generated as previously de-
scribed (Peacock et al., 2010) and snai1 knockdown in infected AVC
explants from Snai1ﬂ/ﬂ mice was determined by qPCR using Taqman
primers against mouse Snai1 (Applied Biosystems).
Endocardial cushion cell culture
2D-Monolayer cell culture: AVC ECs were dissected from E4.5 white
leghorn chicken eggs (Charles River Laboratories) and E11.5 Snai1ﬂ/ﬂ
mouse embryos, trypsinized and cultured for 48 h as a monolayer
prior to treatment as described (Lincoln et al., 2006a).
3D-collagen gel I explant culture: AVC explants were collected from
HH St. 14, and E5.0 chicks, and E11.5 Snai1ﬂ/ﬂ mouse embryos and
placed lumen-side down on 3D-collagen I gels for 2 h prior to treat-
ment as previously described (Inai et al., 2008) (n=5–8).
Following initial culturing, monolayer cells or explants were infected
with 3×106 and 2×107 PFU adenovirus respectively, expressing Snai1
(AdV-Snai1), Cre (AdV-Cre) (Peacock et al., 2010) or GFP (AdV-GFP) di-
luted in serum-free culture media (Lincoln et al., 2006a) for 2 h. Follow-
ing infection, fresh serum-free media was added and cells/explants
were cultured for a further 48 h (2D and 3D culturesmouse culture sys-
tems) or 72 h (2D avian culture system). Alternatively, explants were
treated with recombinant protein of the catalytic domain of MMP15
(caMMP15) (Chemicon/Millipore) at a ﬁnal concentration of 1 μg/mL
in serum-freemedia for 36 h (AVC 3D culture of E5.0 chicken embryos)
or 48 h (AVC 3D culture of HH St. 14 chicken embryos). For controls, ex-
plants were treated with serum-free media alone. For MMP inhibition
studies, explants were subject to 2 μg/mL, 10 μg/mL and 20 μg/mL
211G. Tao et al. / Developmental Biology 359 (2011) 209–221GM6001 (Millipore) or dimethyl sulfoxide (DMSO) in the presence of
either 2×107 PFU AdV-GFP or AdV-Snai1 for 36 h. Following treatment,
cells/explants were ﬁxed in 4% PFA and subject to IHC or collected for
mRNA extraction isolation (dissociated cell culture). To determine the
area covered bymigrating cells, 2D imageswere takenwith anOlympus
SZX7 and the total pixel counts of each cultured AVC explant was mea-
sured using ImagePro Plus software (n=5–8). To quantify the number
of invading cells, immunostained 3-D collagen I gels were captured
using an Olympus Fluoview F-1000 confocal microscope and Z-stack
images were generated from multiple focal planes sections captured
at 5 μm intervals down to the furthest distance of invasion using
Image J software. The fold change in cell invasion andmaximal invading
depth was calculated using ImagePro Plus software by counting the
total pixel number and distance in Z-stacked images. Statistical signiﬁ-
cance over respective controls was determined using Student's t-test
(pb0.05) (n=5).
mRNA isolation, cDNA generation and quantitative PCR
Total mRNA was isolated from cultured monolayer EC cells as
well as fromE10.5 AVC regions from Tie2cre;Snai1ﬂ/+ and Snai1ﬂ/+mice
using TRIzol (Lincoln et al., 2007). 200–400 ng of mRNA was used to
generate cDNA using the high-capacity cDNA kit (Applied Biosys-
tems) (Peacock et al., 2008). cDNA was subject to quantitative PCR
ampliﬁcation (StepOne Plus, Applied Biosystems) using speciﬁc
primers targeting chicken vimentin (Forward: CCGACAGGATGTT-
GACAATG; Reverse: GGATGTGCTGTTCCTGGAGT), αSMA (Forward:
CACCCAACTCTGCTGACTGA; Reverse: ACACCATCCCCAGAGTCAAG), VE-
cadherin (Forward: ATCTCAGACAACGGCAATCC; Reverse: GAAAATTGC
CACCAGTGCTT), claudin1 (Forward: GGAGGATGACCAGGTGAAGA; Re-
verse: TCTGGTGTTAACGGGTGTGA), ﬁbronectin1 (Forward: CGTTCGTC
TCACTGGCTACA; Reverse: ATTAATCCCGACACGACAGC), mmp15 (For-
ward: TGTCGGGGAACAACCTCTTC; Reverse: TTCTCCGTGTCCATCCACTG)
and GAPDH (Forward: GGGTCTTATGACCACTGTCC; Reverse: GTAAGCTT
CCCATTCAGCTCAG), or mouse ﬁbronectin1 (Forward: GGTTGCCTTGCAC-
GATGATA; Reverse: TGAGCTGAACACTGGGTGCT), αSMA (Forward: CTG
ACAGAGGCACCACTGAA; Reverse: CATCTCCAGAGTCCAGCACA), VE-cad-
herin (Forward: ACCGAGAGAAACAGGCTGAA; Reverse: AGACGGGGAA
GTTGTCATTG), E-cadherin (Forward: CAAGGACAGCCTTCTTTTCG; Re-
verse: TGGACTTCAGCGTCACTTTG), snai1 (Forward: TGAGAAGCCATTCT
CCTGCT; Reverse: GCCAGACTCTTGGTGCTTGT), mmp15 (Forward: GAC
CAGTATGGCCCCAACAT; Reverse: CCAATTGGCATGGGGTAGTT) and L7
(Forward: GAAGCTCATCTATGAGAAGGC; Reverse: AAGACGAAGGAGCT
GCAGAAC). Also, Taqman probes (Applied Biosystems) were used to
targeting mouse snai1. Alternatively, E10.5 mouse AVC cDNA was sub-
ject to SuperArray PCR analysis (PAMM-013C-12, SABiosciences) accord-
ing to the manufacturer's instructions (n=5). Following PCR analyses,
the cycle count (Ct) was normalized to at least one housekeeping gene
(GAPDH chicken, L7 mouse, the mean Ct of GAPDH, Gusb, Hsp90ab1)
and the ΔCt and fold changes in experimental samples over controls
were determined as described (Peacock et al., 2008). In addition, the
mesenchymal to endothelial gene expression ratio in E10.5 mouse
AVC cDNA was determined by subtracting the average ΔCt of endo-
thelial (VE-cadherin, E-cadherin) frommesenchymal gene expression
(ﬁbronectin1, αSMA) (n=4). The ratio was further calculated based
upon Power(2,−ΔΔCt). For absolute transcript calculation, the formula
POWER(2, (40−ΔCt+CtL7) was used, with CtL7 denoting the average
cycle count of L7 expression levels. Statistically signiﬁcant differences
in transcript levels were determined using student's t-test on at least 3
independent experiments with pb0.05 considered signiﬁcant after Stu-
dent t-test analysis.
Generation of mice
Snai1ﬂ/ﬂ female mice (Murray et al., 2006) were bred with Tie2cre
males (Kisanuki et al., 2001) to generate heterozygous offspring(Tie2cre;Snai1ﬂ/+) and Cre negative Snai1ﬂ/+ littermate controls at
expected Mendelian ratios. Genotyping was performed by PCR as pre-
viously described (Carver et al., 2001; Lincoln et al., 2007; Murray et
al., 2006). Timed embryonic staged litters of mice were collected at
E10.5 and E13.5 from Snai1ﬂ/ﬂ female mice, counting day E0.5 by evi-
dence of a copulation plug. Embryos were either ﬁxed or AVC tissue
(E10.5) was collected for mRNA extraction. Quantitation of the
number of cells within the ECs from E10.5 and E13.5 Snai1ﬂ/+ and
Tie2cre;Snai1ﬂ/+ mice was determined by counting the number of
DAPI-positive nuclei in at least 3 tissue sections collected from 3 to 4
mutant and control mice.
Chromatin immunoprecipitation (ChIP)
Six canonical E-box consensus sites were identiﬁed within the pro-
moter region of the murine mmp15 gene (NC_000074.5; Chromosome:
8; Location: 8 D1; 8 45.5 cM) and conservation between mouse, rat
and human was determined using the basic local alignment search tool
(NCBI blast). Snai1 binding to mmp15 was evaluated in whole E11.5
mouse embryonic hearts (8–10 hearts per sample, n=3). Protein/DNA
complexes were cross-linked for 10 min in formaldehyde (Sigma) at a
ﬁnal concentration of 0.5%. Fixed tissue was lysed and sonicated three
times for 20 s at 1 minute intervals (Ultrasonic cell disruptor;Microson).
For ChIP, cell lysates were incubated with an antibody against Snai1
(6 μg; Abcam) and incubated overnight at 4 °C with gentle rocking. Im-
munoprecipitation with normal rabbit IgG was used as a negative con-
trol. ChIPs were performed according to the manufacturer's
instructions (EZ ChIP, MilliPore). Immunoprecipitated and input
DNAwere subjected to qPCR using the following primers to amplify
three E-box-rich regions within mmp15: region B (Forward:
GCCACCACACCTGAATCTACTG; Reverse: GTGACTTGGGAAGC
TAGGGTTG), region C (Forward: GAAGCAGGTGGATCTCTGTGAA;
Reverse: TTGCCGGTTGTTCTAGCTGTAG) and region D (Forward:
CCCCA GAGATAGGAGCTAAGCA; Reverse: CCTAACCCGAGGCTTCT-
CAGTA). Primers for region A were also included as a negative control
as canonical E-box siteswere not identiﬁedwithin this region: Forward:
CCAGGAGTCCTAATCCCACACT; Reverse: TGCCCTCTACTGGTGATTTCTG.
Three independent ChIPs were performed and signiﬁcant enrichment
of E-box regions using the Snai1 antibody over IgG control as deter-
mined by qPCR, was determined by student's t-test (pb0.05).
Dual luciferase assays
Luciferase constructs were generated using PCR to amplify three
regions (B, C, D) of themmp15 enhancer region (NCBI accession num-
ber NC_000074) from mouse tail genomic DNA template, using the
following primers: pGL3-mmp15B, forward TAGGTACCATCCCCC-
TACGCAAGAAAAT and reverse TGAGCTCCTCCACTCTGGAGGCACACT
(970 bp). pGL3-mmp15C, forward TAGGTACCTCTCCCATGACCCTTT-
CATC and reverse TGAGCTCCCACTGGTGGACCTCTCTGT (1006 bp).
pGL3-mmp15D forward TAGGTACCGCGTGGGTGTGTAGGGTCTA and
reverse TGAGCTCCCCAAACCGGG TGAGAAG (973 bp). Ampliﬁed re-
gions were gel puriﬁed and ligated into pGL3-basic (promega) using
introduced Sac1 and Kpn1 sites. pcDNA-E47 and pcDNA-E12 plasmids
were kindly provided by Dr. Nakamura (Funato et al., 2001).
Luciferase assays were performed in COS7 cells (ATCC) plated at
2×105 per well of a 24-well plate 24 h prior to transfection with Lipo-
fectamine reagent (Invitrogen) according to manufacturer's instruc-
tions. 200 ng of pGL3-mmp15B, pGL3-mmp15C, pGL3-mmp15D or
empty pGL3, and 200 ng of pcDNA-E47, pcDNA-E12 or empty
pcDNA, were co-transfected into each well, along with 20 ng of
pGL4 (Renilla luciferase, Promega). All transfection were performed
in 400 μl OptiMem for 6 h before the infection of either 3×106 PFU
AdV-Snai1 or AdV-GFP. Cell lysates were collected 48 h following
treatment according to the manufacturer's instructions for dual lucif-
erase assays (Promega). Data is represented as an average percent of
212 G. Tao et al. / Developmental Biology 359 (2011) 209–221luciferase activity in cells infected with AdV-GFP and transfected with
respective plasmids compared to AdV-GFP controls. All experiments
were normalized to Renilla activity and transfected with equal con-
centrations of plasmid DNA (n=3–4).
Results
Reduced snail1 function in vivo leads to hypocellular endocardial cushions
at E10.5
The expression pattern of Snai1 during endocardial cushion (EC)
formation in the atrioventricular canal (AVC) was examined using
immunohistochemistry (IHC) and quantitative PCR (qPCR). At E10.5,
Snai1 expression is observed in endothelial cells overlaying the ECs
(arrowhead, Fig. 1A), in addition to newly transformed mesenchyme
cells within the cushions (arrow, Fig. 1A). Similar expression was ob-
served in ECs within the outﬂow tract regions (data not shown). Nu-
clear expression is also detectable within the myocardium (M,
Fig. 1A). At the mRNA level, snai1 is most highly expressed in AVCFig. 1. Tie2cre;Snai1ﬂ/+ mice have reduced cell number in endocardial cushions at E10.5. (A
endocardial cushions (EC) (arrowhead) and transformed mesenchymal cells within the cush
during differential stages of murine valve development. *pb0.05, statistical signiﬁcance com
snai1ﬂ/+ (C) and Tie2cre;Snai1ﬂ/+ (D) embryos to indicate atrioventricular canal and outﬂow
to show reduced number of nuclei within E10.5 AV ECs in Tie2cre;Snai1ﬂ/+mice compared to c
(SMA ﬁbronectin (FN1)) in Tie2cre;Snai1ﬂ/+ embryos compared to the controls at E10.5. (G) Th
mutant mice, (n=4). *pb0.05, statistical signiﬁcance compared to controls. At, atrium; V,
myocardium.regions at E10.5 when EMT is active, while expression is signiﬁcantly
reduced during post-EMT stages from E12.5 through post natal
(Fig. 1B).
Although the role of Snai1 during EMT in many systems has been
established, its role during EC formation has not been directly exam-
ined. To determine this, we used the Tie2cre transgene to target loss of
snai1 function in endothelial, and derived mesenchymal cells of the
developing ECs in vivo (de Lange et al., 2004; Lincoln et al., 2004). Ho-
mozygous Tie2cre;Snai1ﬂ/ﬂ mice were never recovered after E9.5 and
likely die due to vasculature defects as described following epiblast-
speciﬁc snai1 deletion (Lomeli et al., 2009). However, heterozygous
(Tie2cre;Snai1ﬂ/+) mice are viable through adulthood and show a
50%±17% decrease in snai1 expression in AVC regions at E10.5.
Upon histological examination, Tie2cre;Snai1ﬂ/+ mice display signiﬁ-
cantly less cells within the AVC (Figs. 1C–E) and OFT (data not
shown) ECs compared to littermate controls (Snai1ﬂ/+) at E10.5. In-
signiﬁcant differences in Phospho-histone H3 and cleaved caspase 3
expression suggest that hypocellular ECs observed in Tie2cre;Snai1ﬂ/+
mice at E10.5 was not the result of changes in cell proliferation or) Immunohistochemistry to show Snai1 localization in endothelial cells overlying the
ions (arrow). (B) qPCR to show fold changes in snai1 expression in AVC regions isolated
pared to E10.5, (n=4) (C, D) Alcian blue staining on tissue sections from E10.5 control
tract (OFT) endocardial cushions (EC) (arrows, C–D), (n=3–4). (E) Quantitative analysis
ontrols. (F) qPCR indicates signiﬁcant decreases in expression of mesenchyme cell makers
e ratio of mesenchymal to endothelial gene expression is signiﬁcantly increased in snai1
ventricle; EC, endocardial cushion; AVC, atrioventricular canal; OFT, outﬂow tract; M,
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changes in endothelial cell transformation in E10.5 Tie2cre;Snai1ﬂ/+
mice, qPCR was used to quantitatively examine expression levels of
mesenchymal (αSMA, ﬁbronectin1) and endothelial (VE-cadherin, E-
cadherin) cell markers in AVC regions isolated from Tie2cre;Snai1ﬂ/+
and control mice. Expression of mesenchymal cell markers is signiﬁ-
cantly reduced in Tie2cre;Snai1ﬂ/+ mice (SMA,−7.6-fold, ﬁbronectin1,
−7.4-fold), although insigniﬁcant changes were observed in endo-
thelial markers (Fig. 1F). A consistent decrease in the ratio of mesen-
chymal to endothelial gene transcript levels conﬁrms that observed
decreases in mesenchymal cell marker expression were not results of
decreased cell number within ECs of Tie2cre;Snai1ﬂ/+ mice (Fig. 1G).
Despite a signiﬁcant decrease in the number of mesenchyme cells
within ECs from Tie2cre;Snai1ﬂ/+ mice at E10.5, by E13.5, cell number
is comparable to controls (Figs. 2A–C). This is associatedwith increased
Phospho-histone H3 immunoreactivity, indicative of cell proliferation in
valve primordia from E13.5 Tie2cre;Snai1ﬂ/+mice compared to controls
(Figs. 2D–F). Collectively, these ﬁndings demonstrate that reduced
snai1 function leads to compromised EMT during early stages of EC de-
velopment, however in association with increased proliferation, this
phenotype recovers by later stages.
Mmp15 expression is reduced in atrioventricular canal regions from
E10.5 Tie2cre;Snai1ﬂ/+ mice
To identify downstream genes that may be affected by reduced
snai1 function in developing ECs at E10.5, a gene expression screening
approach was used. This high-throughput assay (Superarray) detects
quantitative changes in expression of over 84 genes associated with
the extracellular matrix (ECM) in AVC regions from E10.5 Tie2cre;
Snai1ﬂ/+ compared to Snai1ﬂ/+ embryos. Table 1 indicates all the
genes that were differentially expressed (pb0.05) in the Superarray
analysis. The most signiﬁcant difference was observed with mmp15
(MT2-MMP), a membrane bound matrix metalloproteinase family
member decreased 5.3-fold in Tie2cre;Snai1ﬂ/+ embryos (Fig. 3A). Inter-
estingly, expression of other family members including mmps1, 2, 3,
7–14was not affected (data not shown). Further IHC analysis shows re-
duced mmp15 protein expression in both endothelial (arrowheads,Fig. 2. Proliferation is increased in endocardial cushions from Tie2cre;Snai1ﬂ/+ mice at E13.5
tions from E13.5 Snai1ﬂ/+ (control) and Tie2cre;Snai1ﬂ/+ embryos to indicate AVC valve prim
ber within valve primordia of Tie2cre;Snai1ﬂ/+ and control mice at E13.5. (D, E) Phospho-Hist
control (D) and Tie2cre;Snai1ﬂ/+ (E) embryos at E13.5. (F) Percentage of Phospho-histone H3
E10.5 and E13.5. n=4, *pb0.05, statistical signiﬁcance compared to controls. IVS, interventrFigs. 3B, C) and mesenchymal cells (arrows, Figs. 3B, C) within ECs,
highlighted by chondroitin sulfate proteoglycan immunoreactivity (red,
Figs. 3B, C). To examine snai1 expression relative to mmp15 during
valve development, qPCR was performed using cDNA from AVC regions
at E10.5, E12.5, E14.5 and post natal stages (Fig. 3D). Approximate tran-
script levels of snai1 and mmp15 showed similar temporal expression
patterns throughout valve development with transcript levels being
highest at E10.5 and gradually declining to post natal stages. Consistently,
co-localization studies show that snai1 andmmp15 are both expressed in
endothelial (arrowhead, Fig. 3F) and mesenchymal (arrow, Fig. 3F) cells
of the valves at E13.5 (Figs. 3E, F). Although due to the expected mem-
brane localization of mmp15 and largely nuclear distribution of snai1,
complete overlap is not always observed. Together, these studies suggest
that snai1 andmmp15 are similarly expressed in developing valve struc-
tures and Snai1 function is required for mmp15 expression during EMT
stages.
Snai1, but not MMP15 is sufﬁcient to initiate EMT and promote cell
transformation in avian atrioventricular canal explants
Understanding the mechanisms of EC EMT has been greatly en-
hanced by studies in the chick using collagen I gel explant systems
(Bernanke and Markwald, 1982; Person et al., 2005). In the avian
model, EC formation is initiated in the looped heart at HH St. 14,
and by HH St.18, EMT is active in all cushion sets (Person et al.,
2005). Worthy of mention, the EMT inductive signals in the chick ap-
pear conserved with the mouse system and include Bmp and Tgfβ sig-
naling (Armstrong and Bischoff, 2004; Combs and Yutzey, 2009;
Person et al., 2005). To investigate if Snai1 and MMP15 are sufﬁcient
to promote EMT in AVC endothelial cells, we employed a published in
vitro collagen I gel explant assay (Bernanke and Markwald, 1982;
Mjaatvedt et al., 1987; Runyan and Markwald, 1983). In this assay,
HH St.14 AV canals are placed on a 3-dimensional (3D) rat-tail colla-
gen I gel with the endothelial cell layer facing down, allowing cells to
migrate onto the surface of the gel (Runyan and Markwald, 1983).
With the myocardium intact, subsets of endothelial cells then invade
the underlying gel as newly transformed mesenchymal cells (Inai et
al., 2008; Mjaatvedt et al., 1987; Runyan and Markwald, 1983). Toand cell number is comparable with controls. (A, B) Alcian blue staining on tissue sec-
ordia structures (outlined). (C) Quantitative analysis to show comparable nuclei num-
one H3 immunoreactivity to detect proliferating cells within valve primordia of Snai1ﬂ/+
positive cells within valve primordia from Tie2cre;Snai1ﬂ/+mice compared to controls at
icular septum.
Table 1
Superarray analysis to show differential gene expression in E10.5 atrioventricular canal
regions from Tie2cre;Snai1ﬂ/+ mice. Following analysis, gene expression was normal-
ized to the mean cycle count of GAPDH, Gusb, Hsp90ab1. Fold changes are shown com-
pared to snai1ﬂ/+.
Gene Fold change p value
Emilin1 (elastin microﬁbril interfacer 1) 0.16±0.05 0.002
Itgβ3 (Integrin-βeta 3) 0.37±0.1 0.039
Lamc1 (laminin-gamma 1) 0.39±0.09 0.030
Mmp15 0.27±0.12 0.028
Sparc (secreted protein, acidic, cysteine-rich) 0.11±0.1 0.006
Spp1 (secreted phosphoprotein 1) 0.14±0.13 0.023
Thbs1 (thrombospondin 1) 0.08±0.1 0.022
Timp2 (tissue inhibitor of metalloproteinase 2) 0.18±0.08 0.016
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to determine localization of Snai1 and Mmp15 in avian ECs at
HHSt.14. As shown in Figs. 4A and B, Snai1 and Mmp15 are similarly
expressed in endothelial (Figs. 4A, B arrowheads) and mesenchyme
(arrows) within the developing cushion. To determine if Snai1 or
MMP15 promote cell transformation, HH St.14 AVC explants were
subjected to Snai1 gain of function by infecting with a GFP-tagged ade-
novirus containing full-length FLAG-labeled mouse Snai1 (AdV-Snai1)
(Fig. 4E), or a control virus with no insert (AdV-GFP) (Fig. 4D). Exoge-
nous levels of murine Snai1 following adenoviral infection were con-
ﬁrmed by western blot to detect the FLAG epitope (data not shown).
For overexpression experiments, the infection efﬁciency of the AdV-
GFP and AdV-Snai1 adenoviruses was comparable with an average of
55.8%±2.29% cells being infected using AdV-GFP and 53.0%±6.45%
withAdV-Snai1. To investigate the function ofMMP15during ECEMT, ex-
plants were alternatively treatedwith an exogenous human recombinantFig. 3.Mmp15 expression is reduced in endocardial cushions from Tie2cre;Snai1ﬂ/+mice at E1
from E10.5 Tie2cre;Snai1ﬂ/+ mice at E10.5 compared to snai1ﬂ/+ controls. pb0.05, statistica
creased mmp15 expression in endothelial (arrowheads) and mesenchymal (arrows) cells o
chondroitin sulfate proteoglycan (CSPG) immunoreactivity to highlight the ECs (B, C), # in
proximate absolute transcript numbers of snai1 and mmp15 at mouse (m) embryonic stag
similar expression patterns between Snai1 (green) and Mmp15 (red) in endothelial (arrow
docardial cushion; At, atria; V, ventricle; RV, right ventricle; LV, left ventricle.MMP15 catalytic domain that functions as a constitutively active form of
MMP15 (caMMP15) (Rebustini et al., 2009). Following 48-hour treat-
ment, explants were subjected to IHC to detect transformedαSMA-pos-
itive mesenchyme cells that migrate over the surface of the collagen gel
away from the original explant site as (indicated by dotted white line)
(Figs. 4D, E, G, H). Compared to AdV-GFP controls (Fig. 4D), AdV-Snai1
treatment (Fig. 4E) signiﬁcantly increases the number ofαSMApositive
cells by over 2-fold (Fig. 4F), whereas compared to respective controls,
caMMP15 does not promote EMT in HH St.14 AV canal explants
(Fig. 4G–H). In addition, increased cell migration in response to AdV-
Snai1 treatment was associated with increased mmp15 expression
(11.83±1.82-fold), as determined by qPCR (Fig. 4J).
To support these studies, and determine if snai1 or MMP15 can pro-
mote cell transformation at later stages of EC development, ECs from
HH St. 25–26 (cE4.5) embryos were removed from the adjacent myo-
cardium, trypsinized and cultured as a 2-dimensional (2D) monolayer.
This system allows for minimal cell–cell contact and therefore changes
in transformation can be examined in a neutral environment (Lincoln et
al., 2006a). Dissociated cells were similarly treated with AdV-Snail,
AdV-GFP, caMMP15 or vehicle and following 72 h, changes in expres-
sion of mesenchymal (vimentin, ﬁbronectin, SMA) and endothelial (VE-
cadherin, claudin1) cell markers were examined by qPCR (Fig. 4K, L).
AdV-Snai1 treatment leads to increased expression of mesenchymal
cell markers vimentin (+12.6-fold) and αSMA (+2.67-fold), and asso-
ciated decreased expression of endothelial cell markers VE-cadherin
(−4.0-fold) and claudin1 (−15.68-fold), compared to AdV-GFP con-
trols (Fig. 4K). However, gene expression indicative of cell transforma-
tion was not affected with caMMP15 treatment compared to
respective vehicle (water) controls (Fig. 4L). These data support a role
of Snai1, but not MMP15, in promoting cell transformation during EC
development.0.5. (A) Superarray qPCR analysis to show decreasedmmp15 expression in AVC regions
l signiﬁcance compared to controls, (n=4). (B, C) Immunohistochemistry to show de-
f the ECs in Tie2cre;snai1ﬂ/+ mice (C) compared to controls (B). Red staining indicates
dicates non-speciﬁc immunoreactivity in myocardium. (D) qPCR analysis to show ap-
es (E) 10.5, 12.5 14.5 and post natal (PN) (n=4). (E, F) Co-localization studies reveal
heads) and mesenchyme (arrow) cells within the endocardial cushion at E13.5. EC, en-
Fig. 4. Snai1, but not MMP15 promotes initiation of endocardial cushion EMT and cell transformation. (A, B) Immunohistochemistry to show Snai1 (A) and Mmp15 (B) expression
in endothelial (arrowheads) and mesenchyme (arrows) cells of the developing EC in the chick at HH St.14. (C) No primary antibody control. Scale bar=50 μm. (D–I) HH St.14 AVC
explants on 3D collagen I gels were treated with AdV-GFP (D), AdV-Snai1 (E), vehicle (water) (G) or caMMP15 (H). Scale bar=200 μm. (F, I) Graph to show fold change in the
number of α-SMA positive cells (red) that have migrated away from the original explant site (dotted line) following treatments. Note increased α-SMA positive cells with AdV-
Snai1 treatment. (J) qPCR to show increased mmp15 expression in AdV-Snai1 treated HH. St. 14 AVC explants compared to AdV-GFP controls. (K, L) qPCR to indicate changes in
gene expression of mesenchymal (vimentin, SMA, ﬁbronectin1 (FN1)) and endothelial (VE-cadherin (VE-cad) and Claudin1 (Cldn-1)) markers in cE4.5 dissociated endocardial cushion
cells treatedwith AdV-Snai1 compared toAdV-GFP controls (K) or caMMP15 compared to vehicle (water) controls (L). Note the increase inmesenchymal gene expression and decrease in
endothelial genes with AdV-Snai1, but not caMMP15 treatment. n=5–8, *pb0.05, compared to respective controls.
215G. Tao et al. / Developmental Biology 359 (2011) 209–221Snai1 and MMP15 are sufﬁcient to promote cell invasion and migration
in developing endocardial cushions
For EC formation to occur, transformed cells from the overlying
endothelial cell layer must invade the cardiac jelly and migrate to
their destination within the expanding cushion (Person et al., 2005).
To mimic EC cell invasion in vitro and examine if Snai1 and MMP15
play a role in this process, HH St. 14 AVC explants with minimal intact
myocardium were placed on 3D collagen I gels and subjected to AdV-
Snai1, AdV-GFP, caMMP15 or vehicle treatment. By reconstructing 2D
stacks of Z series captured by confocal imaging, we observe that both
AdV-Snai1 and caMMP15 treatments increase cell invasion (Figs. 5A–
C, E–G), and the distance traveled by invading cells compared to re-
spective controls (Figs. 5A, B, D, E, F, H). In addition, and consistentwith observations in Figs. 4F and I, the number of αSMA positive
cells appears higher with AdV-Snai1, but not caMMP15 treatment.
These ﬁndings suggest that in ECs, Snai1 and MMP15 play roles in
promoting cell invasion during stages of EMT initiation.
The sufﬁciency of Snai1 and MMP15 to promote migration of
transformed mesenchyme cells within the cardiac jelly of developing
ECs was examined using cE5.0 AVC explants on 3D collagen I gels.
Similar to cell invasion assays, both caMMP15 and AdV-Snai1 treat-
ments increase the area covered by migrating cells on the surface of
the collage I gel, over respective controls (Figs. 6A–D, G). To further
investigate the relationship between Snai1 and Mmps during cell mi-
gration, explants were treated with the pan-MMP inhibitor GM6001
(1×) (Fig. 6E–F) in the presence of AdV-GFP (Fig. 6E) or AdV-Snai1
(Fig. 6F). Compared to AdV-GFP controls (Fig. 6C), inhibition of
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area covered by migrating cells on the gel surface. Further, MMP inhi-
bition in the presence of AdV-Snai1 (Fig. 6F) attenuates the ability of
AdV-Snai1 (Fig. 6D) to promote cell migration in a dose dependent
manner (0.2×, 1×, 2×) (Fig. 6D compared to 6F, 6H). These observa-
tions suggest that Snai1-mediated cell migration in maturing ECs re-
quires MMP activity.
caMMP15 treatment rescues attenuated mesenchyme cell migration in
murine endocardial cushions with reduced snai1 function
Tie2cre;Snai1ﬂ/+ mice display defects in cell transformation (Fig. 1F).
To determine if reduced snai1 function also affects cell migration, AVC
regions isolated from E11.5 Snai1ﬂ/ﬂmice were cultured on 3D collagen
I gels and infected with AdV-Cre resulting in a 2.88-fold decrease in
snai1 expression (Fig. 7F). Compared to AdV-GFP controls (Fig. 7A),
AdV-Cre treatment signiﬁcantly reduces cell migration (Figs. 7A, B, E),
associated with a 4-fold decrease inmmp15 (Fig. 7F). However, cell mi-
gration defects are no longer observed when explants were co-treated
with caMMP15 (Fig. 7B compared to 7D). Therefore suggesting that
caMMP15 treatment is sufﬁcient to rescue attenuated cellmigration de-
fects observed in ECs following reduced snai1 function.Fig. 5. AdV-Snai1 and caMMP15 treatments promote cell migration in HH St. 14 AVC explan
AdV-GFP (A), AdV-Snai1 (B), vehicle (water) (E) or caMMP15 (F). Scale bars in A, B=200 μ
to determine the fold change in the number of cells invading the 3D collagen I gel (C, G), and
treated cultures compared to respective controls (A, E). Immunohistochemistry indicates α-
AdV-Snai1 and caMMP15 treatments. n=5, *pb0.05, statistical signiﬁcance compared to reSnai1 binds and regulates E-box-rich sequences within the promoter region
of mmp15
There are increasing data to suggest that Snai1 may regulate MMP
function in several cell types to promote motility (Joseph et al., 2009;
Ota et al., 2009; Rowe et al., 2009), however molecular interactions
have not been reported. Snail family members regulate transcription
via interactions with E-box binding sites (CANNTG) on target gene
DNA. Within 6000 bp upstream of the ATG transcription start site of
the murine mmp15 gene, a total of six canonical E-box sites have
been identiﬁed denoted within three regions (B–D), each containing
two E-boxes (Fig. 8A). Of note, three of the six E-box sites are con-
served with rat and four with humanmmp15 promoter regions (indi-
cated in Fig. 8A). Snai1 binding to regions B, C and/or D (Fig. 8A) in
mmp15 was assessed using chromatin immunoprecipitation (ChIP)
in whole E11.5 mouse hearts. Region A was included as a negative
control as it does not contain canonical E-box sites. Cross-linked
DNA/protein complexes immunoprecipitated with Snai1 antisera
demonstrate signiﬁcant enrichment of binding within B, C and D re-
gions of mmp15 compared to IgG controls. In contrast, enrichment
was not observed in region A (Fig. 8B). To further assess the function-
ality of E-boxes within regions B, C and D, luciferase assays werets. (A, B, E, F) HH St.14 AVC explants were placed on 3D collagen I gels and treated with
m, E, F=100 μm. Confocal microscopy and Z-stack reconstruction (A, B, E, F) were used
the average maximum distance of invasion (D, H) in AdV-Snai1 (B) and caMMP15 (F)
SMA positive cells (red) and DAPI indicates nuclei (blue). Note increased invasion with
spective controls.
Fig. 6. Loss of MMP activity attenuates snai1-mediated mesenchyme cell migration in developing endocardial cushions in vitro. (A–D) cE5.0 AVC collagen I explants treated with
vehicle (water) (A), caMMP15 (B), AdV-GFP (C) AdV-Snai1 (D), or AdV-GFP (E) or AdV-Snai1 (F) in the presence of the MMP inhibitor (MMP Inhib) GM6001. (G) Quantitation to
show fold change in cell migration area on the surface of the collagen I gel (dotted line) following each treatment *pb0.05, statistical signiﬁcnace compared to respective controls,
#pb0.05, and signiﬁcance compared to AdV-Snai1. (H) Dose–response effects of GM6001 on cell migration in the presence of AdV-Snai1. n=5–8, *pb0.05 compared to 0.2×
treatment.
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pliﬁed sequences targeting each region (pGL3-mmp15B (970 bp),
pGL3-mmp15C (1006 bp), and pGL3-mmp15D (973 bp)). 6 h after
transfection with respective pGL3-mmp15 constructs, cells were fur-
ther infected with AdV-GFP or AdV-Snai1 (as used in Figs. 4–6). De-
spite, enrichment observed by ChIP, AdV-Snai1 infection of cells
transfected with pGL3-mmp15B had no signiﬁcant effect on luciferase
activity of Region B, compared to AdV-GFP:pGL3mmp15B controls
(Fig. 3C). Worthy of mention, signiﬁcant luciferase activity was alsonot observed in AdV-infected cells co-transfected with empty vectors
(data not shown). However, consistent with ChIP ﬁndings, AdV-Snai1
infection signiﬁcantly increased transactivation of mmp15 region C
(pGL3-mmp15C) (38.49%±8.73%) over AdV-GFP, with trends of acti-
vation also observed with Region D (pGL3-mmp15D) (29.0%±10.79%,
p=0.3).
Previous studies have shown that Snail and E2A (E47/E12) family
members regulate activity of common target genes through interac-
tion with speciﬁc E-box sites within the proximal promoter (Bolos
Fig. 7. caMMP15 treatment rescues attenuated cell migration defects observed in AVC explants with Snai1 knockdown. (A–F) E11.5 AVC collagen I explants from snai1ﬂ/ﬂmice trea-
ted with AdV-GFP:DMSO (A), AdV-Cre:DMSO (B), AdV-GFP:caMMP15 (C) or AdV-Cre:caMMP15 (D). (E) Quantiﬁcation to show fold change in the area covered by migrating cells
on the surface of the collagen I gel compared to AdV-GFP:DMSO treatment (*pb0.05). Note decreased migration with AdV-Cre:DMSO treatment compared to AdV-GFP:DMSO, and
rescue with the addition of caMMP15 (AdV-Cre:caMMP15) to levels comparable with AdV-GFP:DMSO. (E) qPCR to show decreased Snai1 expressed with AdV-Cre infection in ex-
plants from snai1ﬂ/ﬂ mice, in addition to downregulation of mmp15. n=4–6, *pb0.05 compared to AdV-GFP.
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or E12 function effects Snai1-mediated transactivation ofmmp15, lucif-
erase assays were repeated in the presence of pcDNA-E47 or pcDNA-
E12. Although E2A family members alone have been shown to act as
transcriptional activators (Takahashi et al., 2004) and repressors (Batlle
et al., 2000; Cano et al., 2000; Perez-Moreno et al., 2001), co-transfection
of pGL3-mmp15B, pGL3-mmp15C or pGL3-mmp15D with pcDNA-E47
or pcDNA-E12 in the presence of AdV-GFP, had no effect onmmp15 ac-
tivity (data not shown). However, co-transfection of pcDNA-E47 in the
presence of AdV-Snai1 signiﬁcantly repressed pGL3-mmp15B
(−70.82%±−19.77%), pGL3-mmp15C (−39.09%±0.46%) and pGL3-
mmp15D (−48.40%±−17.07%). Co-transfection with pcDNA-E12
had no signiﬁcant effect on AdV-Snai1-mediated mmp15 activity (data
not shown). Collectively these studies reveal that Snai1 physically inter-
acts and activates speciﬁc E-box-rich promoter regions within mmp15.
Further, we provide evidence to suggest that E47 function plays an im-
portant role in Snai1-mediated regulation ofmmp15.Discussion
In developing ECs, the EMT program converts endothelial cells
into migratory mesenchymal cells through sequential steps that re-
quire many phenotypic changes (Barrallo-Gimeno and Nieto, 2005;
Thiery et al., 2009). The transcription factor Snai1 has previously
been shown to be indispensible for EMT in many tissues during em-
bryonic development and pathological processes (Nieto, 2009; Thiery
et al., 2009). Despite snai1 expression correlating with EMT activity in
developing valve structures (Liebner et al., 2004; Luna-Zarita et al.,
2010; Meadows et al., 2009; Nath et al., 2008;Wang et al., 2005), a di-
rect role in EC formation has not previously been reported. This is
likely due to the premature lethality of Snai1−/− embryos prior to
cardiogenesis (Carver et al., 2001). To address this limitation, we per-
formed in vivo studies using viable Tie2cre;Snai1ﬂ/+ mice, in parallel
with gain and loss of Snai1 function in AVC explants in vitro. The
goal of this study was to use these previously established systems to
reveal new insights into the role of Snai1 for cell transformation, inva-
sion and migration in developing ECs in the embryonic heart.Prior to EMT, Snai1 is highly expressed in endothelial cells of the
AV canal and expression is maintained in this cell layer throughout
EC formation and valvulogenesis (Figs. 1A, B, 4A) (G. Tao, Unpub-
lished). During EMT, Snai1 expression is also observed in transformed
mesenchyme cells, however expression is downregulated as these
cells differentiate during remodeling stages (Figs. 1A, B, 4A) (Lincoln
et al., 2006b). In this study we show that Snai1 is important in many
sequential steps during EMT beginning with the early transformation
of a subset of cardiac endothelial cells into mesenchyme cells, and
proceeding mesenchyme cell invasion and migration. Further, we
show that MMP activity is required for Snai1-mediated mesenchyme
cell migration and more speciﬁcally, MMP15 activity is sufﬁcient to
rescue migratory phenotypes observed in ECs with targeted snai1
knockdown. Together, ﬁndings from this study suggest that Snai1 is
an important regulator of EC formation and directly binds and regu-
lates mmp15 to promote cell motility during this process.
Snai1-mediated signaling pathways in EMT have been extensively
studied and therefore parallel mechanisms in the developing heart
are considered. Several known upstream regulators of Snai1 are
expressed during cardiogenesis (Luna-Zurita et al., 2010; Molin et
al., 2003; Niessen et al., 2008; Thiery et al., 2009) and manipulation
studies of Notch1, Tgfβs and Bmps, their receptors or intermediate
signaling kinases affect snai1 expression in developing cushions
(Luna-Zarita et al., 2010; Meadows et al., 2009; Wang et al., 2005).
Therefore Snai1-induced EC EMT is likely initiated by these estab-
lished signaling pathways in vivo. Downstream, we can speculate
that Snai1 promotes EMT in developing cushions through mecha-
nisms previously described in other non-cardiac tissues including re-
pression of cell adhesion genes (Cano et al., 2000; Liebner et al., 2004;
Meadows et al., 2009; Nath et al., 2008) and activation of mesenchy-
mal markers (Batlle et al., 2000; Cano et al., 2000; Guaita et al., 2002;
Ikenouchi et al., 2003; Person et al., 2005). In Tie2cre;Snai1ﬂ/+ mice, it
is likely that these signaling pathways are abrogated as a result of re-
duced snai1 function, leading to hypocellular ECs. In addition to atten-
uated transformation, it is plausible that deﬁcient mesenchyme cell
motility and/or imbalanced cell survival also contribute to this pheno-
type. Indeed, our data supports a positive role for Snai1 in cell invasion
and migration in developing ECs, however changes in cell proliferation
Fig. 8. Snai1 binds and regulates E-box rich regions within the promoter region ofmmp15 in whole mouse hearts. (A) Schematic diagram to illustrate the location of six E-box sites
(black solid bars) within three regions (B, C, D) of mmp15 at indicated base pair positions upstream of the ATG start site (+1). Region A is included as a negative control and does
not contain canonical E-box sites. Gray arrows indicate the location of PCR primers used to determine enrichment in DNA/protein complexes following Snai1 pull down. *, # indicate
conservation of E-box sites with human (*) and rat (#) sequences. (B) qPCR to show signiﬁcant enrichment of Snai1 binding to regions B, C and D within the mmp15 promoter
following co-immunprecipitation using whole E11.5 mouse hearts, over IgG controls. Note insigniﬁcant enrichment in region A that does not contain E-box sites. *pb0.05 compared
to IgG controls (n=3). (C) Luciferase assays to show signiﬁcant increased activity of pGL3-mmp15C in the presence of AdV-Snai1, compared to respective AdV-GFP controls. Co-
transfection with pcDNA-E47, represses luciferase activity of pGL3-mmp15B, pGL3-mmp15C and pGL3-mmp15D in the presence of AdV-Snai1, but not AdV-GFP. Data is repre-
sented as a fold change in luciferase activity normalized to Renilla in AdV-Snai1 infected cells co-transfected with indicated plasmids compared to parallel AdV-GFP infected con-
trols. n=3–4, *pb0.05. (D) Mmp15 sequence of Regions B, C and D to show predicted transcription factor binding sites, based on Genomatix analysis with predicted ‘matrix
similarity’ N0.90. The core binding consensus sequences are indicated: AP1F, Activating Protein 1; CEBP, CCAAT/Enhancer Binding Protein; HOXF, Hox Family; PAX8, Pax 2/5/8 bind-
ing site; STAT, Signal transducer and activator of transcription 1; ZFHX, Two-handed zinc ﬁnger homeodomain transcription factors; KLFS, Krueppel like transcription factors; BCDF,
Bicoid-like homeodomain transcription factors; NEUR, NeuroD, beta2, HLH domain; FKND, Fork head domain factor; HAND, Twist subfamily of bHLH factors; MEF3, myocyte-spe-
ciﬁc enhancing factor 3; SMAD, SMAD family; NF1F, nuclear factor 1; NFAT, Nuclear Factor of activated T-cells; YY1F, Activator/repressor binding to transcriptional initiation site;
MyoD, myoblast determining factors; HEAT, Heat shock factors; SP1F, GC-Box factors SP1/GC; ZF02, C2H2 Zinc ﬁnger transcription factors 2.
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trast, cell proliferation was enhanced at E13.5 and levels were sufﬁcient
to increase mesenchyme cell number to levels comparable with con-
trols. Compensation of EC cellularity was similarly reported in Snai2−/−
mice that exhibit hypocellular cushions at E9.5 but not E10.5, and at-
tributed toincreased snai1 expression (Niessen et al., 2008). However,
increased expression of Snail1 family members were not detected in
Tie2cre;Snai1ﬂ/+ mice (data not shown), consistent with observations
reported in snai1−/− mice (Carver et al., 2001). Therefore it is likely
that alternative mechanisms promote the compensatory proliferative
response in ECs from mice with reduced snai1 function.
In addition to developmental processes, Snai1-mediated EMT is ac-
tive in many cancer cell lines and high expression levels correlative
with increased cell migration and metastasis (Thiery et al., 2009; Wu
and Zhou, 2010). A recent study suggested that this pathologic function
of snai1 is mediated through induction ofMT-MMPs, thatwhen activat-
ed, recapitulate snai1's ability to degrade basement membranes and
promote cancer cell migration (Ota et al., 2009). In this study, we pre-
sent several lines of evidence to suggest that in addition to disease, ac-
tivated MT-MMPs also promote cell motility, but not transformation,in the embryonic heart during EC development. Further, we identify
mmp15 (or MT2-MMP) as a direct target gene of Snai1, and a positive
regulator of mesenchyme cell invasion and migration. This ﬁnding ex-
tends the current repertoire of known target genes regulated by Snai1
during EMT beyond cell transformation processes (Batlle et al., 2000;
Cano et al., 2000; Guaita et al., 2002; Ikenouchi et al., 2003; Person et
al., 2005).
In ECs from Tie2cre;Snai1ﬂ/+ mice,mmp15was the only MMP fam-
ily member whose expression was affected by reduced snai1 function,
although decreased trends of the MMP15 target genemmp9were also
observed (data not shown). The widespread protein localization of
mmp15 throughout the ECs suggests that this mmp family member
may target ECM substrates in both endothelial and mesenchymal
cells. Type IV collagen is a known substrate of MMP15 in basement
membranes (Hotary et al., 2000; Rebustini et al., 2009) and its degra-
dation in endothelial cells lining the AV canal and OFT regions is im-
portant for EMT and EC formation (Song et al., 2000). Therefore leading
to the conclusion that mmp15 may facilitate endothelial cell delamina-
tion, independent of transformation in developing ECs. Mmp15's func-
tion in mesenchymal cells is less speculative and its activity correlates
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plants. Like mmp15, other family members including mmp2 and 9 are
also highly expressed inmesenchyme cells during ECEMT,where they fa-
cilitate ECM degradation to promote mesenchymal cell motility through
the hyaluronan-rich cardiac jelly (Rupp et al., 2008; Shelton and Yutzey,
2007). The observation that Snai1 directly binds and activates mmp15 is
consistent with a recent study showing that Snai2 (slug) binds and regu-
lates activity of another family member, membrane-type 4 MMP (Huang
et al., 2009). Findings from this current study have revealed a new role
for snai1 as a transcriptional activator ofmmp15 to promote cellmigration
during EC EMT.
The observation that Snai1 acts as a transcriptional activator of
mmp15 is somewhat surprising as despite emerging evidence to sup-
port this function (Batlle et al., 2000; Cano et al., 2000; Guaita et al.,
2002; Hwang et al., 2011; Ikenouchi et al., 2003; Person et al., 2005),
Snai1 ismore commonly known as a repressor (Nieto, 2009). In our sys-
tem, Snai1 increases mmp15 transactivity by 38%, which could be con-
sidered a subtle, albeit signiﬁcant, difference. As this study is one of
the ﬁrst to show direct transactivation of target genes by Snai1, it is
not clear if the addition of co-activators (or removal of co-repressors)
could increase mmp15 activity above this level. In contrast to AdV-
Snai1 treatment, E47 alone has no effect onmmp15, yet E47 in the pres-
ence of AdV-Snai1, leads to repression. As previous studies have shown
that Snai1 and E47 regulate common target genes through interaction
with speciﬁc E-boxes (Bolos et al., 2003) (Peinado et al., 2004; Perez-
Moreno et al., 2001), we speculate that overexpressed E47 binds with
no functional effect, to prevent Snai1 interaction and transactivation
ofmmp15. This mechanismmay also in part explain the subtle increase
inmmp15 activity with AdV-Snai1 treatment: as endogenous E47 com-
petes with Snai1 for E-box binding. This competition may also be de-
pendent on differential binding afﬁnities of Snail1 and E47 on the
same target genes (Bolos et al., 2003). Although this might explain the
lost activation of mmp15 by Snai1, the mechanism in which Snai1 and
E47 cooperate to repressmmp15 is not clear, but likely requires recruit-
ment of co-repressor machinery at the putative E-box sites. Our studies
using the in vivo mouse and in vitro chick models, strongly suggest that
Snai1 positively regulatesmmp15 in these systems, therefore suggesting
that endogenous E2A expression levels are low at this time. However, it
remains unknown how Snai1-E2A work together to regulate mmp15
during post-EMT stages when cell motility is less active.
There is increasing evidence that adult heart valve disease has ori-
gins in embryonic development (Combs and Yutzey, 2009). Tie2cre;
Snai1ﬂ/+ mice display EC defects by E10.5, although heterozygous em-
bryos recover by E13.5 and adult valve morphology is grossly indistinct
from control animals. Therefore alternative approaches are needed to
thoroughly examine the requirement of Snai1 during EC development,
for adult cardiac function. Nonetheless this study provides new insights
into the regulatory functions of Snai1 throughmmp15, to form the pool
of precursor cells within the ECs that later give rise to the diversiﬁed
mature valve structures (Lincoln et al., 2004). Worthy of mention,
snai1 expression is detectable at post-EMT stages in endothelial cells
that overlay the maturing valve leaﬂets (G. Tao, Unpublished). It re-
mains unknown why valve endothelial cells at these later stages do
not undergo EMT in vivo, even in the presence of Snai1. As discussed
above in the context of mmp15, this is likely dependent upon the
maturation of VECs during valvulogenesis and therefore related
to the absence (or presence) of some Snai1 targets or co-factors,
some potential candidates are indicated in Fig. 8D (Barrallo-
Gimeno and Nieto, 2005). However, as treatment strategies for degen-
erative heart valve disease are limited, it would be beneﬁcial to deter-
mine if snai1 can provide a genetic ‘cue’ to reactivate developmental
EMT programs in post-natal valves as a means to maintain or replace
the interstitial valve cell population during life. During later stages of val-
vulogenesis Snai1 may have additional functions, and based upon its
repressive function on ECM genes (Seki et al., 2003) and positive regula-
tion of mmp activity (this study), it is plausible that Snai1 is involved invalve remodeling (Lincoln et al., 2006b). Further, alterations in the regu-
lation of Snai1 during this process may have implications in degenerative
valve disease characterized by pathological remodeling and associated
with increased MMP-2, −9 and −13 expression (Kaden et al., 2004;
Rabkin et al., 2001; Soini et al., 2001). In conclusion, this current study
has revealed new information into the role of snai1 during early heart
valve formation that may provide insights into mechanisms of congen-
ital heart valve disease that result from defects in EC formation.Acknowledgments
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